In vitro and in vivo studies of plant-produced Atezolizumab as a potential immunotherapeutic antibody

Reading Time: < 1 minute
Nicotiana benthamiana as a potential source for producing anti-dengue virusD54 neutralizing therapeutic antibody

Reading Time: < 1 minute
Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana

Reading Time: < 1 minute
Glycoengineering of plant-produced Pembrolizumab enhances FcRn binding and extends serum half-life in mice

Reading Time: < 1 minute
